Home

latte Varietà Svantaggio atorvastatina ricerche correlate serie Ottimizzazione del motore di ricerca Sede centrale

Comparison of atorvastatin versus fenofibrate in reaching lipid targets and  influencing biomarkers of endothelial damage in patients with familial  combined hyperlipidemia - Metabolism - Clinical and Experimental
Comparison of atorvastatin versus fenofibrate in reaching lipid targets and influencing biomarkers of endothelial damage in patients with familial combined hyperlipidemia - Metabolism - Clinical and Experimental

Atorvastatin attenuates post-implant tissue degeneration of cardiac  prosthetic valve bovine pericardial tissue in a subcutaneous animal model -  International Journal of Cardiology
Atorvastatin attenuates post-implant tissue degeneration of cardiac prosthetic valve bovine pericardial tissue in a subcutaneous animal model - International Journal of Cardiology

Novel prospects of statins as therapeutic agents in cancer - ScienceDirect
Novel prospects of statins as therapeutic agents in cancer - ScienceDirect

Immediate Antioxidant and Antiplatelet Effect of Atorvastatin via  Inhibition of Nox2 | Circulation
Immediate Antioxidant and Antiplatelet Effect of Atorvastatin via Inhibition of Nox2 | Circulation

Atorvastatin Reduces Circulating Osteoprogenitor Cells and T‐Cell RANKL  Expression in Osteoporotic Women: Implications for the Bone–Vascular Axis -  Rattazzi - 2016 - Cardiovascular Therapeutics - Wiley Online Library
Atorvastatin Reduces Circulating Osteoprogenitor Cells and T‐Cell RANKL Expression in Osteoporotic Women: Implications for the Bone–Vascular Axis - Rattazzi - 2016 - Cardiovascular Therapeutics - Wiley Online Library

Atorvastatin Reduces Circulating Osteoprogenitor Cells and T‐Cell RANKL  Expression in Osteoporotic Women: Implications for the Bone–Vascular Axis -  Rattazzi - 2016 - Cardiovascular Therapeutics - Wiley Online Library
Atorvastatin Reduces Circulating Osteoprogenitor Cells and T‐Cell RANKL Expression in Osteoporotic Women: Implications for the Bone–Vascular Axis - Rattazzi - 2016 - Cardiovascular Therapeutics - Wiley Online Library

Atorvastatin - Wikipedia
Atorvastatin - Wikipedia

Impact of statin therapy intensity on endothelial progenitor cells after  percutaneous coronary intervention in diabetic patients. The REMEDY-EPC  late study - International Journal of Cardiology
Impact of statin therapy intensity on endothelial progenitor cells after percutaneous coronary intervention in diabetic patients. The REMEDY-EPC late study - International Journal of Cardiology

Atorvastatin modulates anti-proliferative and pro-proliferative signals in  Her2/neu-positive mammary cancer - ScienceDirect
Atorvastatin modulates anti-proliferative and pro-proliferative signals in Her2/neu-positive mammary cancer - ScienceDirect

Green Chemistry in the Synthesis of Pharmaceuticals | Chemical Reviews
Green Chemistry in the Synthesis of Pharmaceuticals | Chemical Reviews

3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase and Isoprenylation  Inhibitors Induce Apoptosis of Vascular Smooth Muscle Cells in Culture |  Circulation Research
3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase and Isoprenylation Inhibitors Induce Apoptosis of Vascular Smooth Muscle Cells in Culture | Circulation Research

Effect of rosuvastatin in patients with chronic heart failure (the GISSI-HF  trial): a randomised, double-blind, placebo-controlled trial - The Lancet
Effect of rosuvastatin in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial - The Lancet

Atorvastatin reduces long pentraxin 3 expression in vascular cells by  inhibiting protein geranylgeranylation - ScienceDirect
Atorvastatin reduces long pentraxin 3 expression in vascular cells by inhibiting protein geranylgeranylation - ScienceDirect

Renal effects of atorvastatin and rosuvastatin in patients with diabetes  who have progressive renal disease (PLANET I): a randomised clinical trial  - The Lancet Diabetes & Endocrinology
Renal effects of atorvastatin and rosuvastatin in patients with diabetes who have progressive renal disease (PLANET I): a randomised clinical trial - The Lancet Diabetes & Endocrinology

Atorvastatin Reduces Circulating Osteoprogenitor Cells and T‐Cell RANKL  Expression in Osteoporotic Women: Implications for the Bone–Vascular Axis -  Rattazzi - 2016 - Cardiovascular Therapeutics - Wiley Online Library
Atorvastatin Reduces Circulating Osteoprogenitor Cells and T‐Cell RANKL Expression in Osteoporotic Women: Implications for the Bone–Vascular Axis - Rattazzi - 2016 - Cardiovascular Therapeutics - Wiley Online Library

Immediate Antioxidant and Antiplatelet Effect of Atorvastatin via  Inhibition of Nox2 | Circulation
Immediate Antioxidant and Antiplatelet Effect of Atorvastatin via Inhibition of Nox2 | Circulation

Atorvastatin Ameliorates Sildenafil-Induced Penile Erections in  Experimental Diabetes by Inhibiting Diabetes-Induced RhoA/Rho-Kinase  Signaling Hyperactivation - The Journal of Sexual Medicine
Atorvastatin Ameliorates Sildenafil-Induced Penile Erections in Experimental Diabetes by Inhibiting Diabetes-Induced RhoA/Rho-Kinase Signaling Hyperactivation - The Journal of Sexual Medicine

Renal effects of atorvastatin and rosuvastatin in patients with diabetes  who have progressive renal disease (PLANET I): a randomised clinical trial  - The Lancet Diabetes & Endocrinology
Renal effects of atorvastatin and rosuvastatin in patients with diabetes who have progressive renal disease (PLANET I): a randomised clinical trial - The Lancet Diabetes & Endocrinology

3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase and Isoprenylation  Inhibitors Induce Apoptosis of Vascular Smooth Muscle Cells in Culture |  Circulation Research
3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase and Isoprenylation Inhibitors Induce Apoptosis of Vascular Smooth Muscle Cells in Culture | Circulation Research

Atorvastatin reduces long pentraxin 3 expression in vascular cells by  inhibiting protein geranylgeranylation - ScienceDirect
Atorvastatin reduces long pentraxin 3 expression in vascular cells by inhibiting protein geranylgeranylation - ScienceDirect

Atorvastatin - Wikipedia
Atorvastatin - Wikipedia

Immediate Antioxidant and Antiplatelet Effect of Atorvastatin via  Inhibition of Nox2 | Circulation
Immediate Antioxidant and Antiplatelet Effect of Atorvastatin via Inhibition of Nox2 | Circulation

Fluvastatin and Atorvastatin Affect Calcium Homeostasis of Rat Skeletal  Muscle Fibers in Vivo and in Vitro by Impairing the Sarcoplasmic  Reticulum/Mitochondria Ca2+-Release System | Journal of Pharmacology and  Experimental Therapeutics
Fluvastatin and Atorvastatin Affect Calcium Homeostasis of Rat Skeletal Muscle Fibers in Vivo and in Vitro by Impairing the Sarcoplasmic Reticulum/Mitochondria Ca2+-Release System | Journal of Pharmacology and Experimental Therapeutics

52nd ANMCO Congress Abstracts Orals
52nd ANMCO Congress Abstracts Orals

Atorvastatin inhibits oxidative stress via adiponectin-mediated NADPH  oxidase down-regulation in hypercholesterolemic patients - Atherosclerosis
Atorvastatin inhibits oxidative stress via adiponectin-mediated NADPH oxidase down-regulation in hypercholesterolemic patients - Atherosclerosis

Atorvastatin modulates anti-proliferative and pro-proliferative signals in  Her2/neu-positive mammary cancer - ScienceDirect
Atorvastatin modulates anti-proliferative and pro-proliferative signals in Her2/neu-positive mammary cancer - ScienceDirect

Fluvastatin and Atorvastatin Affect Calcium Homeostasis of Rat Skeletal  Muscle Fibers in Vivo and in Vitro by Impairing the Sarcoplasmic  Reticulum/Mitochondria Ca2+-Release System | Journal of Pharmacology and  Experimental Therapeutics
Fluvastatin and Atorvastatin Affect Calcium Homeostasis of Rat Skeletal Muscle Fibers in Vivo and in Vitro by Impairing the Sarcoplasmic Reticulum/Mitochondria Ca2+-Release System | Journal of Pharmacology and Experimental Therapeutics